Surgical Science Sweden AB
STO:SUS
During the last 3 months Surgical Science Sweden AB insiders bought 974k SEK , and have not sold any shares. The stock price has dropped by 25% over this period (open performance analysis).
The last transaction was made on Apr 11, 2025 by Tom Englund (CEO) , who bought 974k SEK worth of SUS shares.
During the last 3 months Surgical Science Sweden AB insiders bought 974k SEK , and have not sold any shares. The stock price has dropped by 25% over this period (open performance analysis).
The last transaction was made on Apr 11, 2025 by Tom Englund (CEO) , who bought 974k SEK worth of SUS shares.
Surgical Science Sweden AB
Glance View
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2017-06-19. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet